Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Cancer × Midazolam × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 3 Neoplasms 2 Melanoma 2 Advanced Malignancies 2 Urothelial Cancer 1 Thyroid Neoplasms 1 Solid Tumors, KRAS Mutation 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Leiomyosarcoma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Hematologic Neoplasms 1 Healthy Adult Participants 1 Glioma 1 Colorectal Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Central Nervous System Neoplasms 1

Interventions

Nivolumab 6 Ipilimumab 2 Gemcitabine 2 zaleplon 1 temsirolimus 1 relatlimab 1 regorafenib 1 linrodostat 1 Vorinostat 1 Trastuzumab 1 Standard of Care 1 Sirolimus 1 Rehabilitation 1 Paclitaxel 1 Oxaliplatin 1 Injections 1 IFL protocol 1 Health Services Needs and Demand 1 Everolimus 1 Clinical Trials, Phase IV as Topic 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡